Bjartell A - Search Results

1

STAT3 inhibition with galiellalactone effectively targets the prostate cancer stem-like cell population.

Canesin G, Maggio V, Palominos M, Stiehm A, Contreras HR, Castellón EA, Morote J, Paciucci R, Maitland NJ, Bjartell A, Hellsten R. Canesin G, et al. Among authors: bjartell a. Sci Rep. 2020 Aug 18;10(1):13958. doi: 10.1038/s41598-020-70948-5. Sci Rep. 2020. PMID: 32811873 Free PMC article.

2

A highly conserved protein secreted by the prostate cancer cell line PC-3 is expressed in benign and malignant prostate tissue.

Valtonen-André C, Bjartell A, Hellsten R, Lilja H, Härkönen P, Lundwall A. Valtonen-André C, et al. Among authors: bjartell a. Biol Chem. 2007 Mar;388(3):289-95. doi: 10.1515/BC.2007.032. Biol Chem. 2007. PMID: 17338636

3

Galiellalactone is a novel therapeutic candidate against hormone-refractory prostate cancer expressing activated Stat3.

Hellsten R, Johansson M, Dahlman A, Dizeyi N, Sterner O, Bjartell A. Hellsten R, et al. Among authors: bjartell a. Prostate. 2008 Feb 15;68(3):269-80. doi: 10.1002/pros.20699. Prostate. 2008. PMID: 18163422

4

Molecular pathways in the progression of hormone-independent and metastatic prostate cancer.

Wegiel B, Evans S, Hellsten R, Otterbein LE, Bjartell A, Persson JL. Wegiel B, et al. Among authors: bjartell a. Curr Cancer Drug Targets. 2010 Jun;10(4):392-401. doi: 10.2174/156800910791208562. Curr Cancer Drug Targets. 2010. PMID: 20384583

5

Galiellalactone inhibits stem cell-like ALDH-positive prostate cancer cells.

Hellsten R, Johansson M, Dahlman A, Sterner O, Bjartell A. Hellsten R, et al. Among authors: bjartell a. PLoS One. 2011;6(7):e22118. doi: 10.1371/journal.pone.0022118. Epub 2011 Jul 11. PLoS One. 2011. PMID: 21779382 Free PMC article.

6

Expression of Id proteins is regulated by the Bcl-3 proto-oncogene in prostate cancer.

Ahlqvist K, Saamarthy K, Syed Khaja AS, Bjartell A, Massoumi R. Ahlqvist K, et al. Among authors: bjartell a. Oncogene. 2013 Mar 21;32(12):1601-8. doi: 10.1038/onc.2012.175. Epub 2012 May 14. Oncogene. 2013. PMID: 22580608

7

The tumour suppressor miR-34c targets MET in prostate cancer cells.

Hagman Z, Haflidadottir BS, Ansari M, Persson M, Bjartell A, Edsjö A, Ceder Y. Hagman Z, et al. Among authors: bjartell a. Br J Cancer. 2013 Sep 3;109(5):1271-8. doi: 10.1038/bjc.2013.449. Epub 2013 Aug 6. Br J Cancer. 2013. PMID: 23922103 Free PMC article.

8

The fungal metabolite galiellalactone interferes with the nuclear import of NF-κB and inhibits HIV-1 replication.

Pérez M, Soler-Torronteras R, Collado JA, Limones CG, Hellsten R, Johansson M, Sterner O, Bjartell A, Calzado MA, Muñoz E. Pérez M, et al. Among authors: bjartell a. Chem Biol Interact. 2014 May 5;214:69-76. doi: 10.1016/j.cbi.2014.02.012. Epub 2014 Mar 11. Chem Biol Interact. 2014. PMID: 24631022

9

Galiellalactone is a direct inhibitor of the transcription factor STAT3 in prostate cancer cells.

Don-Doncow N, Escobar Z, Johansson M, Kjellström S, Garcia V, Munoz E, Sterner O, Bjartell A, Hellsten R. Don-Doncow N, et al. Among authors: bjartell a. J Biol Chem. 2014 Jun 6;289(23):15969-78. doi: 10.1074/jbc.M114.564252. Epub 2014 Apr 22. J Biol Chem. 2014. PMID: 24755219 Free PMC article.

10

The STAT3 Inhibitor Galiellalactone Effectively Reduces Tumor Growth and Metastatic Spread in an Orthotopic Xenograft Mouse Model of Prostate Cancer.

Canesin G, Evans-Axelsson S, Hellsten R, Sterner O, Krzyzanowska A, Andersson T, Bjartell A. Canesin G, et al. Among authors: bjartell a. Eur Urol. 2016 Mar;69(3):400-4. doi: 10.1016/j.eururo.2015.06.016. Epub 2015 Jul 2. Eur Urol. 2016. PMID: 26144873

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

410 results

Search Page

Filters